Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2

Vollenberg R*, Tepasse P-R*, Kühn JE, Hennies M, Strauss, M Rennebaum F, Schomacher T, Boeckel G, Lorentzen E*, Bokemeyer A*, Nowacki TM* (*equally contributed)

Research article (journal) | Peer reviewed

Details about the publication

Journal: Biomedicines

Volume: 10

Issue: 171

Status: Published

Release year: 2022 (13/01/2022)

Language in which the publication is written: English

DOI: 10.3390/biomedicines10010171

Link to the full text: https://www.mdpi.com/2227-9059/10/1/171

Keywords: SARS-CoV-2; mRNA-Impfungen; Impfantwort bei IBD; Serokonversion; COVID-19

Authors from the University of Münster

Boeckel, Göran Ramin	Medical Clinic of Internal Medicine D (Nephrology and Rheumatology) (Med D)
Hennies, Marc Tim	Institute of Virology
Kühn, Joachim	Institute of Virology
Lorentzen, Eva	Institute of Virology
Nowacki, Tobias Max	Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B)
Rennebaum, Florian	Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B)
Schomacher, Tina	Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B)
Tepasse, Phil-Robin	Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B)
Vollenberg, Richard	Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B)

Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2

Details about the publication

Authors from the University of Münster

Operated by

Top-Links